01 · THE CUSTOMER PROBLEM
Regenerative systems require a controlled balance of porosity, mechanics, mass transport, cell compatibility and degradation.
Mykito translates high-purity chitosan into porous scaffolds, fibers and printable hydrogels engineered around the target tissue environment.
Tissue engineering requires a material that balances structure, cell compatibility, mass transport and controlled degradation.
02 · RECOMMENDED STARTING POINT
Start with the material designed for the decision.
Chitosan can be formed into porous scaffolds, fibers and printable hydrogels, then combined with other biomaterials to create application-specific three-dimensional environments.
Without the shell
Controlled fungal sourcing supports a traceable, non-animal supply strategy.
Specification engineered
MW, DDA, purity, charge density and format are selected around the target result.
Application ready
Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.
One technical partner
Material selection, formulation support and the validation plan are connected from the first sample.
03 · PERFORMANCE TARGETS
Build toward outcomes a buyer can measure.
Scaffolds
Porous sponges, fibers and composite matrices create three-dimensional structures for cell and tissue research.
3D bioprinting
Chitosan and its derivatives can contribute viscosity, charge and biological functionality to composite bioinks.
Biocompatible matrices
High-purity material supports systematic evaluation of cell-material interaction in the final scaffold design.
Controlled degradation
ABC and crosslinking strategies allow scaffold persistence to be developed around the target tissue response.
04 · GO / NO-GO CRITERIA
Define the evidence before testing begins.
The first program is designed around three decision-making outputs—not an open-ended material trial.
Porosity, mechanics and printability
Cell compatibility and mass transport
Sterilization and controlled degradation
05 · FROM SAMPLE TO DECISION
A practical application program,
not a bag of powder.
Define
Agree on the function, baseline, constraints and measurable success criteria.
Screen
Select the MW, DDA, purity, dose and physical format that fit the application.
Validate
Test the winning system in the finished formulation, device, process or use environment.
Recommended first request: A scaffold or bioink ChitoGene grade with EndoFree and ABC options.
Start the Sample Brief06 · WHY CHITOSAN
A functional tissue interface
Coatings, fibers, films, gels and porous matrices can create a modifiable interface on metals, polymers, composites or wound-contact structures.
There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.
Biocompatibility, endotoxin, sterilization, mechanics and degradation are qualified around the final device and contact classification.